{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:51:09Z","timestamp":1791190269941,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.maturitas.2011.11.008","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T20:46:31Z","timestamp":1322858791000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Measuring anti-M\u00fcllerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?"],"prefix":"10.1016","volume":"71","author":[{"given":"R.A.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.B.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2011.11.008_bib0005","doi-asserted-by":"crossref","first-page":"e8772","DOI":"10.1371\/journal.pone.0008772","article-title":"Human ovarian reserve from conception to the menopause","volume":"5","author":"Wallace","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0010","first-page":"200","article-title":"Initial and cyclic recruitment of ovarian follicles","volume":"21","author":"McGee","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/humrep\/deg019","volume":"18","author":"Yong","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0020","first-page":"105","article-title":"Female reproductive aging is marked by decreased secretion of dimeric inhibin","volume":"84","author":"Welt","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0022-3468(81)80827-5","article-title":"The ontogeny of M\u00fcllerian inhibiting substance in the gonads of the chicken","volume":"16","author":"Hutson","year":"1981","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum M\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antim\u00fcllerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0040","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antim\u00fcllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0045","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-M\u00fcllerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0050","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mrd.20338","article-title":"Evidence for a role for anti-M\u00fcllerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane","volume":"71","author":"Gigli","year":"2005","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0055","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-M\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ydbio.2003.10.009","article-title":"Oocyte regulation of anti-M\u00fcllerian hormone expression in granulosa cells during ovarian follicle development in mice","volume":"266","author":"Salmon","year":"2004","journal-title":"Dev Biol"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0070","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/humrep\/deh508","article-title":"Anti-M\u00fcllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation","volume":"19","author":"La Marca","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-M\u00fcllerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0080","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-M\u00fcllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2014implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-M\u00fcllerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0090","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","article-title":"The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos","volume":"150","author":"Majumder","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.rbmo.2010.11.005","article-title":"Anti-M\u00fcllerian hormone-based prediction model for a live birth in assisted reproduction","volume":"22","author":"La Marca","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0100","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/humrep\/der182","article-title":"Anti-M\u00fcllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF","volume":"26","author":"Yates","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0105","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2010-0930","article-title":"Serum levels of anti-M\u00fcllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients","author":"Hagen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0110","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Anti-M\u00fcllerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0115","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.fertnstert.2010.08.022","article-title":"Nomogram for the decline in serum antim\u00fcllerian hormone: a population study of 9,601 infertility patients","volume":"95","author":"Nelson","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.rbmo.2011.05.006","article-title":"External validation of nomogram for the decline in serum anti-M\u00fcllerian hormone in women: a population study of 15,834 infertility patients","volume":"23","author":"Nelson","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.fertnstert.2010.10.011","article-title":"Age-specific serum anti-M\u00fcllerian hormone values for 17,120 women presenting to fertility centers within the United States","volume":"95","author":"Seifer","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0130","doi-asserted-by":"crossref","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","article-title":"A validated model of serum anti-M\u00fcllerian hormone from conception to menopause","volume":"6","author":"Kelsey","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0135","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/oxfordjournals.humrep.a019422","article-title":"A model conforming the decline in follicle numbers to the age of menopause in women","volume":"11","author":"Faddy","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0140","article-title":"Data-driven assessment of the human ovarian reserve","author":"Kelsey","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.fertnstert.2009.02.022","article-title":"Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-M\u00fcllerian hormone levels","volume":"94","author":"Chang","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0155","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/humrep\/del201","article-title":"The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer","volume":"21","author":"Anderson","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.rbmo.2009.11.010","article-title":"Anti-M\u00fcllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results","volume":"20","author":"Decanter","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0165","unstructured":"Brougham MFH, Crofton P, Johnson EJ, et al. Anti-M\u00fcllerian hormone is a marker of gonadotoxicity in pre- and post-pubertal girls treated for cancer: a prospective study. Eur J Cancer, submitted for publication."},{"key":"10.1016\/j.maturitas.2011.11.008_bib0170","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/humrep\/deg473","article-title":"Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-M\u00fcllerian hormone, inhibin B and ovarian ultrasound","volume":"18","author":"Bath","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0175","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2006-2374","article-title":"Anti-M\u00fcllerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood","volume":"92","author":"van Beek","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0180","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.bjc.6603814","article-title":"Predictors of ovarian reserve in young women with breast cancer","volume":"96","author":"Lutchman Singh","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0185","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/den487","article-title":"Assessment of ovarian reserve in adult childhood cancer survivors using anti-M\u00fcllerian hormone","volume":"24","author":"Lie Fong","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0190","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1093\/humrep\/den248","article-title":"Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study","volume":"23","author":"Rosendahl","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0195","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/jrf.0.0870257","article-title":"Ovarian cyclicity and follicular recruitment in unilaterally ovariectomized mice","volume":"87","author":"Gosden","year":"1989","journal-title":"J Reprod Fertil"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0200","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/07357900701829777","article-title":"A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer","volume":"26","author":"Anders","year":"2008","journal-title":"Cancer Invest"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0205","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2009.02.043","article-title":"Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age","volume":"94","author":"Rosendahl","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0210","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.25037","article-title":"Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy","volume":"116","author":"Yu","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0215","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2010-2582","article-title":"Pretreatment serum anti-M\u00fcllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer","volume":"96","author":"Anderson","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0220","article-title":"Pre-chemotherapy anti-M\u00fcllerian hormone Is predictive of long-term ovarian function In women with breast cancer","volume":"32","author":"Anderson","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0225","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-M\u00fcllerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0230","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-M\u00fcllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0235","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2011.06.016","article-title":"Evaluation of serum antim\u00fcllerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea","volume":"96","author":"Li","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/humupd\/dml060","article-title":"The anti-M\u00fcllerian hormone and ovarian cancer","volume":"13","author":"La Marca","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0245","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.contraception.2010.09.007","article-title":"Serum anti-M\u00fcllerian hormone level is not altered in women using hormonal contraceptives","volume":"83","author":"Li","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0250","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/humrep\/deq071","article-title":"Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases","volume":"25","author":"van den Berg","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0255","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.fertnstert.2009.07.1676","article-title":"Longitudinal assessment of antim\u00fcllerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin","volume":"93","author":"Nelson","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0260","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0265","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Anti-M\u00fcllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0270","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Anti-M\u00fcllerian hormone predicts menopause: a long-term follow-up study in normoovulatory women","volume":"96","author":"Broer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2011.11.008_bib0275","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/humupd\/dmi024","article-title":"Genetic studies to identify genes underlying menopausal age","volume":"11","author":"Kok","year":"2005","journal-title":"Hum Reprod Update"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211003744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211003744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:52:52Z","timestamp":1759913572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512211003744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0378512211003744"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.11.008","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring anti-M\u00fcllerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}